Skip to main content
Premium Trial:

Request an Annual Quote

Aventis Buys, Uses Gene-IT Software

NEW YORK, May 27 -   Gene-IT has sold Aventis its Biofacet software, and has completed two comparative genomics projects for the big pharma, Gene-IT said today.

 

The studies included an anti-infective study in which Gene-IT used Biofacet to determine the protein sequences of bacterial genomes, and an anti-fungal study, in which the company identified DNA shared among fungal species.

 

The parties did not disclose the financial terms of the agreement. Gene-IT is a Paris-based bioinformatics company.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.